Research Article: Comparison of Azvudine and Nirmatrelvir/Ritonavir and Combined Use in Patients with COVID-
Introduction:
Azvudine and nirmatrelvir/ritonavir are the two most commonly used antiviral drugs for treating COVID- in China. Previous studies have shown that both azvudine and nirmatrelvir/ritonavir are effective antiviral treatments for COVID-. – However, few studies have compared the effectiveness of azvudine and nirmatrelvir/ritonavir for COVID- treatment.
Read more